HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.

Abstract
alpha-Galactosylceramide (alpha-GalCer) is the prototype compound for studying the presentation of glycolipids on CD1d molecules to natural killer T (NKT) lymphocytes. A single i.v. dose of glycolipid triggers a cascade of events involving the production of several cytokines over the course of a day, a short-lived activation of NKT and natural killer (NK) cells, and a more prolonged adaptive T cell immune response if certain antigens are given together with alpha-GalCer. We find that a recently described analogue, alpha-C-galactosylceramide (alpha-C-GalCer), more potently induces these innate and adaptive immune responses in mice. alpha-C-GalCer acts as a more effective trigger for IL-12 and IFN-gamma production, although it minimally elicits IL-4 and TNF-alpha release into the serum. Also, alpha-C-GalCer better mobilizes NKT and natural killer cells to resist B16 melanoma. To help understand these effects, we find that alpha-C-GalCer binds more stably to dendritic cells than alpha-GalCer and that dendritic cells loaded with alpha-C-GalCer induce larger and more long lasting NKT cell responses in vivo. When glycolipid is targeted to dendritic cells in spleen together with antigens in dying cells, such as irradiated tumor cells, alpha-C-GalCer is active as an adjuvant for T cell-mediated immunity at lower doses, just 20 ng per mouse, where it is also able to up-regulate the required CD40L costimulatory molecule on NKT cells. Therefore, alpha-C-GalCer represents a glycolipid that binds more stably to dendritic cells and acts as a more effective link between innate and adaptive immunity in vivo.
AuthorsShin-Ichiro Fujii, Kanako Shimizu, Hiroaki Hemmi, Mikiko Fukui, Anthony J Bonito, Guangwu Chen, Richard W Franck, Moriya Tsuji, Ralph M Steinman
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 103 Issue 30 Pg. 11252-7 (Jul 25 2006) ISSN: 0027-8424 [Print] United States
PMID16844772 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • CD11c Antigen
  • Cytokines
  • Galactosylceramides
  • Glycolipids
  • alpha-galactosylceramide
  • Interleukin-12
  • Interferon-gamma
Topics
  • Animals
  • CD11c Antigen (biosynthesis)
  • Cytokines (metabolism)
  • Dendritic Cells (cytology, metabolism)
  • Galactosylceramides (metabolism, physiology)
  • Glycolipids (chemistry, metabolism)
  • Immune System (physiology)
  • Interferon-gamma (metabolism)
  • Interleukin-12 (metabolism)
  • Killer Cells, Natural (cytology)
  • Melanoma, Experimental (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: